ERBB2 and gastric cancer: High incidence of HER2 heterogeneity is found in up to 79.3% of HER2-positive gastric cancers within the same tumor (‘intratumoral heterogeneity’) [9] and in up to 11% between primary gastric cancers and metastatic tumors (‘intertumoral heterogeneity’) [18].